• Controlling Lipid Nanoparticle Size to Optimize mRNA Deliver

  2026-07-07

  This study demonstrates that precise adjustment of aqueous-to-lipid phase ratios during lipid nanoparticle (LNP) manufacturing directly tunes particle size, which in turn impacts mRNA expression efficiency in both in vitro and in vivo systems. These findings provide actionable parameters for optimizing LNPs as delivery vehicles for mRNA-based research and therapeutics.

• Proteomic Dissection of Platycodin D’s Pro-apoptotic Mechani

  2026-07-07

  This study uses multidimensional proteomics to reveal how Platycodin D induces apoptosis in non-small cell lung cancer by binding RFC4 and suppressing the Notch signaling pathway. The findings clarify a novel mechanism of action, offering translational insight for targeted therapy strategies and proteomic workflow design.

• ECE-1c Stabilization Drives Stemness and Cisplatin Resistanc

  2026-07-06

  This study demonstrates that stabilizing the ECE-1c isoform in non-small cell lung cancer (NSCLC) cells enhances cancer stem cell traits, invasiveness, and resistance to cisplatin. The findings highlight a CK2-dependent, ET-1–independent pathway driving aggressive cancer phenotypes and suggest CK2 inhibition as a potential therapeutic avenue.

• Parathyroid hormone (1-34) (human): Mechanism and Research B

  2026-07-06

  Parathyroid hormone (1-34) (human) is a potent peptide fragment that enables precise control of calcium homeostasis and bone metabolism in research. It demonstrates nanomolar potency at receptor targets and is a validated tool for osteoporosis and kidney disease modeling. This article provides detailed, evidence-backed insights into its mechanism, experimental performance, and workflow integration.

• Fluorinated-Sorbitol Polyplexes Elevate mRNA Vaccine Deliver

  2026-07-05

  This study introduces a dual-mechanism mRNA delivery platform using fluorinated-sorbitol polyplexes (PFS), which enhances both cellular uptake and endosomal escape. The findings demonstrate robust mRNA vaccine efficacy, offering a promising alternative to lipid nanoparticles and new directions for intracellular delivery research.

• Imidazoline Antagonists Enhance Insulin by Blocking β-Cell K

  2026-07-04

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors increase insulin release in vitro by directly inhibiting ATP-sensitive potassium (K+) channels in pancreatic β-cells, rather than solely through adrenergic blockade. These findings clarify the mechanism underlying the insulinotropic effect, with implications for diabetes pharmacology and ion channel research.

• Entamoeba histolytica Prx Induces Autophagy via TLR4-TRIF in

  2026-07-03

  This study uncovers a novel pathogenic mechanism by which peroxiredoxin (Prx) from Entamoeba histolytica activates autophagy in host macrophages through the TLR4-TRIF pathway. These findings highlight the complex interplay between parasite factors and host innate immune regulation, offering new insight into host-pathogen interactions and potential experimental strategies for dissecting autophagy-related pathways.

• Protease Inhibitor Cocktail (EDTA-Free): Precision for Compl

  2026-07-03

  Explore how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) elevates protein stability in challenging cell and tissue extractions. This article uniquely examines the molecular rationale and assay-level decision-making for optimal protease inhibition, guiding researchers beyond generic workflows.

• Macrocyclic Inhibitors Reveal Smoothened Modulation in Hedge

  2026-07-02

  This study introduces optimized macrocyclic inhibitors targeting the Hedgehog pathway, revealing new insights into Smoothened (Smo) receptor antagonism. The findings advance our understanding of Smo modulation and offer improved tools for Hedgehog pathway activation assays and cancer research.

• L. plantarum P101 Mitigates Alcoholic Steatosis via AMPK Act

  2026-07-02

  This study reveals that Lactiplantibacillus plantarum P101 alleviates alcohol-induced hepatic lipid accumulation in mice through AMPK pathway activation. Using an AMPK inhibitor, the research clarifies the probiotic's mechanism and highlights the integral role of gut microbiota and metabolites in alcoholic fatty liver disease management.

• Translating Angiotensin (1-7) Mechanisms to Next-Gen Therapi

  2026-07-01

  This thought-leadership article explores how the mechanistic nuances of Angiotensin (1-7)—from Mas receptor signaling to anti-fibrotic and anti-inflammatory effects—can be leveraged by translational researchers for innovative therapeutic development. Integrating recent protocol advances, competitive insights, and evidence from the latest literature, it charts a strategic path for maximizing the impact of this peptide in preclinical and emerging translational applications.

• Nile Red: Illuminating Lipid Metabolism and Translational Im

  2026-07-01

  This thought-leadership article explores the mechanistic underpinnings and translational significance of Nile Red in lipid metabolism research, integrating recent autophagy findings and providing actionable guidance for optimizing intracellular lipid droplet staining. By leveraging advanced imaging strategies and comparative insights from clinical hepatoprotective studies, the article positions APExBIO Nile Red as a cornerstone tool for lipid research and bridges the gap between bench discoveries and clinical implications.

• Triiodothyronine (T3): Precision Thyroid Hormone for Metabol

  2026-06-30

  Triiodothyronine (T3) is a potent thyroid hormone essential for studying gene regulation and metabolic processes. APExBIO’s high-purity T3 (SKU C6407) offers reproducible results in thyroid hormone signaling pathway research. This dossier outlines its molecular action, evidence basis, and best-practice integration in experimental workflows.

• In Vitro Activity of Sisomicin vs. Other Aminoglycosides in

  2026-06-30

  This article examines Stewart and Bodey's foundational study of sisomicin, a new aminoglycoside antibiotic, comparing its in vitro efficacy against a broad panel of clinical isolates to that of established agents like kanamycin, gentamicin, and tobramycin. The findings clarify both the spectrum and limitations of sisomicin in the context of antibiotic resistance research, providing key reference points for scientists selecting antibiotics for microbiology investigations.

• YM-155 Hydrochloride: Survivin Inhibitor for Advanced Cancer

  2026-06-29

  YM-155 hydrochloride is a nanomolar-potency survivin inhibitor that enables precise dissection of apoptotic mechanisms in cancer models. This guide unpacks applied workflows, protocol enhancements, and troubleshooting strategies for maximizing YM-155 hydrochloride’s translational impact in apoptosis inhibitor research.

16336 records 1/1090 page Next 12345 下5页 Last page